Correlation Between BioNTech and Calmare Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BioNTech and Calmare Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioNTech and Calmare Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BioNTech SE and Calmare Therapeutics, you can compare the effects of market volatilities on BioNTech and Calmare Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioNTech with a short position of Calmare Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioNTech and Calmare Therapeutics.

Diversification Opportunities for BioNTech and Calmare Therapeutics

0.1
  Correlation Coefficient

Average diversification

The 3 months correlation between BioNTech and Calmare is 0.1. Overlapping area represents the amount of risk that can be diversified away by holding BioNTech SE and Calmare Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Calmare Therapeutics and BioNTech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioNTech SE are associated (or correlated) with Calmare Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Calmare Therapeutics has no effect on the direction of BioNTech i.e., BioNTech and Calmare Therapeutics go up and down completely randomly.

Pair Corralation between BioNTech and Calmare Therapeutics

Given the investment horizon of 90 days BioNTech SE is expected to generate 0.1 times more return on investment than Calmare Therapeutics. However, BioNTech SE is 10.18 times less risky than Calmare Therapeutics. It trades about -0.01 of its potential returns per unit of risk. Calmare Therapeutics is currently generating about -0.5 per unit of risk. If you would invest  15,311  in BioNTech SE on September 19, 2024 and sell it today you would lose (4,150) from holding BioNTech SE or give up 27.1% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy0.81%
ValuesDaily Returns

BioNTech SE  vs.  Calmare Therapeutics

 Performance 
       Timeline  
BioNTech SE 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in BioNTech SE are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong basic indicators, BioNTech is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Calmare Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Calmare Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Calmare Therapeutics is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

BioNTech and Calmare Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BioNTech and Calmare Therapeutics

The main advantage of trading using opposite BioNTech and Calmare Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioNTech position performs unexpectedly, Calmare Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Calmare Therapeutics will offset losses from the drop in Calmare Therapeutics' long position.
The idea behind BioNTech SE and Calmare Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Complementary Tools

AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format